Summary
Copper-histidine is the treatment of choice in Menkes disease but bears the potential risk of copper overload and induced liver cirrhosis. We report normal copper concentrations of liver tissue over an 8-year treatment period with copper-histidine.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Verena Peters
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Kroepfl, T., Mair, E., Deutsch, J. et al. Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease. J Inherit Metab Dis 29, 593 (2006). https://doi.org/10.1007/s10545-006-0312-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0312-1